1-3 of 3
Flavio Crippa, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy

Simonetta Viviani, MD, Francesco Spina, MD, Arabella Mazzocchi, Maria Galbiati, Flavio Crippa, MD, Lucia Farina, MD PhD, Anna Guidetti, MD, Massimo Di Nicola, Liliana Franca Devizzi, MD, Paola Matteucci, MD, Michele Magni, MD, Anna Dodero, Alessandro M. Gianni, MD, Paolo Corradini, MD
Journal: Blood
Blood (2016) 128 (22): 3009.
https://doi.org/10.1182/blood.V128.22.3009.3009
Published: 2016
Journal Articles

Phase II Trial of Combination of the Histone Deacetylase Inhibitor ITF2357 and Meclorethamine Demonstrates Clinical Activity and Safety in Heavily Pretreated Patients with Relapsed/Refractory Hodgkin Lymphoma (HL)

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Simonetta Viviani, MD, Valeria Bonfante, MD, Pinuccia Valagussa, MD, Alfonso Marchianò, MD, Flavio Crippa, MD, Stefania Zambelli, MD, Cinzia Fasola, MD, Paolo Corradini, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2008) 112 (11): 2586.
https://doi.org/10.1182/blood.V112.11.2586.2586
Published: 2008
Journal Articles

Prognostic Value of Positron Emission Tomography (PET) Scan in Patients with Relapsed Hodgkin Lymphoma or Aggressive Non-Hodgkin Lymphoma Receiving Salvage Chemotherapy Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation.

Anna Dodero, MD, Roberto Crocchiolo, MD, Francesca Patriarca, MD, Fabio Ciceri, MD, Nicolo’ Frungillo, MD, Roberto Fanin, MD, Rosalba Miceli, MD, Andrea Assanelli, MD, Raffaella Milani, MD, Flavio Crippa, MD, Paolo Corradini, MD
Journal: Blood
Blood (2007) 110 (11): 3039.
https://doi.org/10.1182/blood.V110.11.3039.3039
Published: 2007